Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_46403 | 73 | 1.53 | Mlig455_020746 | Neo: - Age: - |
Mlig455_020746 {REF} {Length: 668} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_47399.1} {RNA815_38310} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.387 | 1.66 | 0.99968 | 1.00000 | |
RegionR2 | 0.697 | 1.66 | 0.55304 | 0.91801 | |
RegionR3 | 0.568 | 1.66 | 0.58332 | 1.00000 | |
RegionR4 | 2.064 | 1.66 | 0.16696 | 0.42881 | |
RegionR5 | 0.526 | 1.66 | 0.60486 | 0.96226 | |
RegionR6 | 0.963 | 1.66 | 0.43171 | 0.99534 | |
RegionR7 | 1.414 | 1.66 | 0.34789 | 0.98524 | |
RegionR8 | -3.845 | 1.66 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.416 | 1.66 | 1.00000 | 1.00000 | |
RegenerationR2 | 0.723 | 1.66 | 0.33875 | 0.77412 | |
RegenerationR3 | 0.518 | 1.66 | 0.60743 | 0.91156 | |
RegenerationR4 | -0.123 | 1.66 | 0.90551 | 1.00000 | |
RegenerationR5 | 1.054 | 1.66 | 0.26098 | 0.69234 | |
RegenerationR6 | 0.16 | 1.66 | 0.88211 | 1.00000 | |
RegenerationBL | 2.252 | 1.66 | 0.16271 | 0.48355 | |
RegenerationTP | 2.429 | 1.66 | 0.25509 | 0.70260 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_46403 | 73 | 1.53 | Mlig455_020746 | Neo: - Age: - |
5 | 1.000 | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_020746 {REF} {Length: 668} {TRANSSPLICED} {NoTransDecoderORF} {RNA1310_47399.1} {RNA815_38310} | |
2. | MligTC455_46894 | 109 | 2.26 | Mlig455_017820 | Neo: - Age: - |
SCRT1 | 1.865 | - | - | - | 0.910 | 0.955 | - | Mlig455_017820 {REF} {Length: 2221} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=84.8]; C2H2-type zinc finger [PF13894.8, score=67.2]; Zinc-finger double domain [PF13465.8, score=60.4]; C2H2-type zinc finger [PF13912.8, score=33.8]; Zinc ribbon domain [PF09723.12, score=21.4]} {Human: ENSG00000261678, SCRT1, scratch family transcriptional repressor 1, [RH, Score=252, Expect=1e-78]; ENSG00000284923, SCRT1, scratch family transcriptional repressor 1, [RH, Score=252, Expect=1e-78]; ENSG00000215397, SCRT2, scratch family transcriptional repressor 2, [RH, Score=247, Expect=2e-77]} {Mouse: ENSMUSG00000048385, Scrt1, scratch family zinc finger 1, [RH, Score=261, Expect=2e-82]; ENSMUSG00000060257, Scrt2, scratch family zinc finger 2, [RH, Score=255, Expect=2e-80]} {Dmel: FBgn0004880, scrt, scratch, [RH, Score=279, Expect=8e-86]} {Celegans: WBGene00000468, ces-1, CES-1; CEll death Specification, [RH, Score=219, Expect=1e-67]} {Smed: dd_Smed_v6_18952_0_1, dd_Smed_v6_18952_0_1, [RH, Score=291, Expect=5e-94]} {RNA1310_21478.1} {RNA815_23567} |
3. | MligTC455_14606 | 16 | 0.32 | Mlig455_040933 | Neo: - Age: - |
1.811 | - | - | - | 0.968 | 0.843 | - | Mlig455_040933 {REF} {Length: 2220} {Pfam: Glycine rich protein [PF12810.9, score=19.4]} {RNA1310_51057} {RNA815_59956} | |
4. | MligTC455_32522 | 134 | 2.8 | Mlig455_040944 | Neo: - Age: - |
1.74 | - | - | - | 0.959 | 0.781 | - | Mlig455_040944 {REF} {Length: 2473} {RNA1509_46835} {RNA1310_21335.2} {RNA815_21965} | |
5. | MligTC455_30550 | 68 | 1.42 | Mlig455_036076, Mlig455_036098, Mlig455_049725, Mlig455_070544 | Neo: - |
1.726 | - | - | - | 0.951 | 0.775 | - | Mlig455_036076 {REF} {Length: 2084} {Pfam: OB-fold nucleic acid binding domain [PF01336.27, score=49.4]; Replication protein A OB domain [PF16900.7, score=47.1]; RecG wedge domain [PF17191.6, score=18.9]} {Smed: dd_Smed_v6_3342_0_1, dd_Smed_v6_3342_0_1, [Score=90.5, Expect=8e-20]} {RNA1509_10085} {RNA1310_6627.1} {RNA815_3343} Mlig455_036098 {REF} {Length: 3104} {Pfam: OB-fold nucleic acid binding domain [PF01336.27, score=49.4]; Replication protein A OB domain [PF16900.7, score=47.1]; RecG wedge domain [PF17191.6, score=18.9]} {Smed: dd_Smed_v6_3342_0_1, dd_Smed_v6_3342_0_1, [Score=90.5, Expect=8e-20]} {RNA1509_10085} {RNA1310_6627.1} {RNA815_3343} Mlig455_049725 {REF} {Length: 1908} {Pfam: OB-fold nucleic acid binding domain [PF01336.27, score=50.2]; Replication protein A OB domain [PF16900.7, score=47.8]; RecG wedge domain [PF17191.6, score=19.6]; OB-fold nucleic acid binding domain [PF13742.8, score=19.2]} {Smed: dd_Smed_v6_3342_0_1, dd_Smed_v6_3342_0_1, [Score=90.5, Expect=4e-20]} {RNA1509_10085} {RNA1310_8434} {RNA815_3343} Mlig455_070544 {REF} {Length: 1465} {Pfam: OB-fold nucleic acid binding domain [PF01336.27, score=49.8]; Replication protein A OB domain [PF16900.7, score=42.5]; RecG wedge domain [PF17191.6, score=19.5]; OB-fold nucleic acid binding domain [PF13742.8, score=19.4]} {Smed: dd_Smed_v6_3342_0_1, dd_Smed_v6_3342_0_1, [Score=88.2, Expect=6e-19]} {RNA1509_10085} {RNA1310_6627.1} {RNA815_3343} |
|
6. | MligTC455_26517 | 54 | 1.13 | Mlig455_050870, Mlig455_053969 | Neo: - Age: logFC(26M/2M)=-0.514 |
1.652 | - | - | 0.702 | - | 0.950 | - | Mlig455_050870 {REF} {Length: 3430} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=54.1]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=32.7]} {Smed: dd_Smed_v6_6819_0_2, dd_Smed_v6_6819_0_2, [Score=152, Expect=9e-42]} {RNA1509_35362} {RNA1310_8376} {RNA815_4529} Mlig455_053969 {REF} {Length: 989} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=74.2]} {Smed: dd_Smed_v6_16441_0_5, dd_Smed_v6_16441_0_5, [Score=51.6, Expect=3e-07]} {RNA1509_35362} {RNA1310_21423.2} {RNA815_13686} |
|
7. | MligTC455_23491 | 83 | 1.73 | Mlig455_059101 | Neo: - Age: - |
0.976 | - | - | - | 0.976 | - | - | Mlig455_059101 {REF} {Length: 2808} {TRANSSPLICED} {RNA1509_38122} {RNA1310_8876.1} {RNA815_14615.1} | |
8. | MligTC455_41931 | 60 | 1.24 | Mlig455_020212 | Neo: - Age: - |
GATA3 | 0.975 | - | - | - | 0.975 | - | - | Mlig455_020212 {REF} {Length: 2116} {Pfam: GATA zinc finger [PF00320.29, score=98.7]; TFIIB zinc-binding [PF08271.14, score=22.7]; Putative transposase DNA-binding domain [PF07282.13, score=18.8]} {Human: ENSG00000107485, GATA3, GATA binding protein 3, [Score=214, Expect=5e-63]; ENSG00000179348, GATA2, GATA binding protein 2, [Score=211, Expect=1e-61]} {Mouse: ENSMUSG00000015619, Gata3, GATA binding protein 3, [RH, Score=216, Expect=5e-64]} {Dmel: FBgn0001138, grn, grain, [Score=201, Expect=2e-56]} {Celegans: WBGene00001249, elt-1, Transcription factor elt-1, [Score=191, Expect=5e-55]} {Smed: dd_Smed_v6_17393_0_1, dd_Smed_v6_17393_0_1, [RH, Score=211, Expect=2e-62]} {RNA1310_61837} |
9. | MligTC455_27012 | 250 | 5.22 | Mlig455_013108, Mlig455_013199 | Neo: - |
SLC35B2 | 0.974 | - | - | - | 0.974 | - | - | Mlig455_013108 {REF} {Length: 3246} {Pfam: UAA transporter family [PF08449.13, score=184.8]} {Human: ENSG00000157593, SLC35B2, solute carrier family 35 member B2, [Score=288, Expect=6e-92]} {Mouse: ENSMUSG00000037089, Slc35b2, solute carrier family 35, member B2, [Score=286, Expect=2e-91]} {Dmel: FBgn0038524, sll, slalom, [Score=280, Expect=1e-88]} {Celegans: WBGene00004206, pst-1, Adenosine 3'-phospho 5'-phosphosulfate transporter 1, [Score=201, Expect=5e-59]} {Smed: dd_Smed_v6_6703_0_1, dd_Smed_v6_6703_0_1, [Score=306, Expect=2e-99]} {RNA1509_43501, RNA1509_54969, RNA1509_7614} {RNA1310_5665.1, RNA1509_43501, RNA1509_54969} {RNA1509_43501, RNA1509_54969, RNA815_3554} Mlig455_013199 {REF} {Length: 3314} {Pfam: UAA transporter family [PF08449.13, score=185.1]; EamA-like transporter family [PF00892.22, score=19.2]; Triose-phosphate Transporter family [PF03151.18, score=19.1]} {Human: ENSG00000157593, SLC35B2, solute carrier family 35 member B2, [Score=287, Expect=1e-91]} {Mouse: ENSMUSG00000037089, Slc35b2, solute carrier family 35, member B2, [Score=285, Expect=7e-91]} {Dmel: FBgn0038524, sll, slalom, [Score=277, Expect=9e-88]} {Celegans: WBGene00004206, pst-1, Adenosine 3'-phospho 5'-phosphosulfate transporter 1, [Score=199, Expect=2e-58]} {Smed: dd_Smed_v6_6703_0_1, dd_Smed_v6_6703_0_1, [Score=302, Expect=1e-97]} {RNA1509_29229, RNA1509_33233, RNA1509_7614} {RNA1310_5665.1, RNA1509_29229, RNA1509_33233, RNA1509_7614} {RNA1509_29229, RNA1509_33233, RNA1509_7614, RNA815_3554} |
10. | MligTC455_52574 | 51 | 1.07 | Mlig455_007160 | Neo: - Age: logFC(26M/2M)=-0.446 |
0.97 | - | - | - | 0.970 | - | - | Mlig455_007160 {REF} {Length: 3359} {Pfam: Variant SH3 domain [PF07653.19, score=22.2]} {Mouse: ENSMUSG00000071636, Rimbp3, RIMS binding protein 3, [Score=52.0, Expect=4e-06]} {Smed: dd_Smed_v6_14584_0_1, dd_Smed_v6_14584_0_1, [RH, Score=159, Expect=4e-41]} {RNA1509_44466} {RNA1310_1009.1} {RNA815_1316.1} | |
11. | MligTC455_02314 | 28 | 0.58 | Mlig455_059382 | Neo: - Age: - |
0.963 | - | - | - | - | 0.963 | - | Mlig455_059382 {REF} {Length: 161} {NoTransDecoderORF} {RNA1509_55144} {RNA1310_22958} {RNA815_59301} | |
12. | MligTC455_52290 | 54 | 1.12 | Mlig455_000596, Mlig455_030333 | Neo: - Age: - |
SCNN1A | 0.961 | - | - | - | 0.961 | - | - | Mlig455_000596 {REF} {Length: 2088} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=165.8]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=50.8, Expect=4e-06]} {Smed: dd_Smed_v6_20466_0_1, dd_Smed_v6_20466_0_1, [RH, Score=404, Expect=1e-133]} {RNA1310_20263} {RNA815_20553} Mlig455_030333 {REF} {Length: 2092} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=111.3]} {Human: ENSG00000111319, SCNN1A, sodium channel epithelial 1 alpha subunit, [Score=57.4, Expect=2e-08]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=53.5, Expect=3e-07]} {Smed: dd_Smed_v6_20466_0_1, dd_Smed_v6_20466_0_1, [Score=279, Expect=2e-88]} {RNA1310_20263} {RNA815_20553} |
13. | MligTC455_12720 | 17 | 0.36 | Mlig455_023405 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_023405 {REF} {Length: 1217} {RNA1310_90924} | |
14. | MligTC455_47661 | 372 | 7.74 | Mlig455_051810 | Neo: - Age: - |
FBN2 | 0.958 | - | - | - | 0.958 | - | - | Mlig455_051810 {REF} {Length: 1487} {Pfam: Complement Clr-like EGF-like [PF12662.9, score=111.3]; EGF-like domain [PF00008.29, score=88.5]; Calcium-binding EGF domain [PF07645.17, score=43.1]; Coagulation Factor Xa inhibitory site [PF14670.8, score=31.5]; EGF domain [PF12947.9, score=29.7]; EGF-like domain [PF07974.15, score=21.2]} {Human: ENSG00000138829, FBN2, fibrillin 2, [Score=139, Expect=2e-32]; ENSG00000166147, FBN1, fibrillin 1, [Score=136, Expect=1e-31]} {Mouse: ENSMUSG00000027204, Fbn1, fibrillin 1, [Score=142, Expect=1e-33]; ENSMUSG00000024598, Fbn2, fibrillin 2, [Score=141, Expect=2e-33]} {Dmel: FBgn0000463, Dl, dorsal, [Score=79.3, Expect=1e-14]} {Celegans: WBGene00013416, Y64G10A.7, [Score=77.0, Expect=6e-14]} {Smed: dd_Smed_v6_1886_0_1, dd_Smed_v6_1886_0_1, [Score=166, Expect=3e-42]} {RNA1509_16874} {RNA1310_1071.1} {RNA815_313.1} |
15. | MligTC455_51883 | 225 | 4.68 | Mlig455_038026, Mlig455_038936 | Neo: Irradiation Age: - Region-enriched R5: 4.340/0.02386 |
GLRA2 | 0.957 | - | - | - | 0.957 | - | - | Mlig455_038026 {REF} {Length: 2683} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=127.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.3]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=288, Expect=3e-92]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=279, Expect=8e-89]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=276, Expect=8e-88]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=285, Expect=3e-91]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=278, Expect=3e-88]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=273, Expect=1e-86]} {Dmel: FBgn0024963, GluClalpha, [Score=275, Expect=1e-87]} {Celegans: WBGene00001591, glc-1, Glutamate-gated chloride channel alpha, [RH, Score=269, Expect=5e-85]} {Smed: dd_Smed_v6_18238_0_1, dd_Smed_v6_18238_0_1, [Score=239, Expect=5e-74]} {RNA1509_53717} {RNA1310_10428.1} {RNA815_24141} Mlig455_038936 {REF} {Length: 6984} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=127.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.3]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=288, Expect=3e-92]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=279, Expect=8e-89]; ENSG00000145888, GLRA1, glycine receptor alpha 1, [Score=276, Expect=8e-88]} {Mouse: ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=285, Expect=3e-91]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=278, Expect=3e-88]; ENSMUSG00000000263, Glra1, glycine receptor, alpha 1 subunit, [Score=273, Expect=1e-86]} {Dmel: FBgn0024963, GluClalpha, [Score=275, Expect=1e-87]} {Celegans: WBGene00001591, glc-1, Glutamate-gated chloride channel alpha, [RH, Score=269, Expect=5e-85]} {Smed: dd_Smed_v6_18238_0_1, dd_Smed_v6_18238_0_1, [Score=239, Expect=5e-74]} {RNA1509_53717} {RNA1310_10428.1} {RNA815_24141} |
16. | MligTC455_02544 | 9 | 0.19 | Mlig455_035271 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_035271 {REF} {Length: 1211} {NoTransDecoderORF} {RNA1509_2609} {RNA1310_34122.1} {RNA815_6796.2} | |
17. | MligTC455_18383 | 21 | 0.44 | Mlig455_011777 | Neo: - Age: - |
0.956 | - | - | - | 0.956 | - | - | Mlig455_011777 {REF} {Length: 1117} {NoTransDecoderORF} {RNA1509_27597} {RNA1310_38232.1, RNA1509_27597} {RNA1509_27597, RNA815_9852.1} | |
18. | MligTC455_10577 | 22 | 0.46 | Mlig455_044548 | Neo: - Age: - |
0.955 | - | - | - | 0.955 | - | - | Mlig455_044548 {REF} {Length: 953} {Pfam: Bacterial protein of unknown function (DUF948) [PF06103.13, score=26.2]; YscO-like protein [PF16789.7, score=22.3]; Type III secretion protein YscO [PF07321.14, score=18.7]} {RNA1509_56109} {RNA1310_140905} {RNA815_33461} | |
19. | MligTC455_28294 | 127 | 2.64 | Mlig455_006642 | Neo: - Age: Up-Down-Up |
ANKRD17 | 0.955 | - | - | - | 0.955 | - | - | Mlig455_006642 {REF} {Length: 7026} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=380.4]; Ankyrin repeats (many copies) [PF13637.8, score=222.9]; Ankyrin repeat [PF13606.8, score=165.6]; Ankyrin repeats (many copies) [PF13857.8, score=142.3]; Ankyrin repeat [PF00023.32, score=136.2]; Nucleotide-Binding Domain 94 of RH [PF16830.7, score=23.4]} {Human: ENSG00000132466, ANKRD17, ankyrin repeat domain 17, [Score=139, Expect=7e-32]} {Mouse: ENSMUSG00000055204, Ankrd17, ankyrin repeat domain 17, [Score=139, Expect=3e-32]} {Dmel: FBgn0039590, CG10011, [Score=90.5, Expect=1e-17]} {Celegans: WBGene00012124, T28D6.4, [Score=84.7, Expect=5e-16]} {Smed: dd_Smed_v6_5303_0_2, dd_Smed_v6_5303_0_2, [Score=106, Expect=9e-23]} {RNA1509_44391} {RNA1310_30754} {RNA815_10474.1} |
20. | MligTC455_28394 | 11 | 0.22 | Mlig455_065222 | Neo: - Age: - |
0.955 | - | - | - | 0.955 | - | - | Mlig455_065222 {REF} {Length: 337} {NoTransDecoderORF} {RNA1509_51515} {RNA1310_19438} {RNA815_57736} | |
21. | MligTC455_38479 | 142 | 2.97 | Mlig455_049645, Mlig455_054626 | Neo: - Age: Up-Down-Down |
CDK19, CDK8 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_049645 {REF} {Length: 3873} {Pfam: Protein kinase domain [PF00069.27, score=76.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=29.9]} {Human: ENSG00000132964, CDK8, cyclin dependent kinase 8, [Score=284, Expect=1e-90]; ENSG00000155111, CDK19, cyclin dependent kinase 19, [Score=280, Expect=7e-89]} {Mouse: ENSMUSG00000029635, Cdk8, cyclin-dependent kinase 8, [Score=289, Expect=1e-92]; ENSMUSG00000038481, Cdk19, cyclin-dependent kinase 19, [Score=279, Expect=2e-88]} {Dmel: FBgn0015618, Cdk8, Cyclin-dependent kinase 8, [Score=273, Expect=4e-87]} {Celegans: WBGene00000409, cdk-8, Cyclin-dependent kinase 8, [Score=235, Expect=4e-71]} {Smed: dd_Smed_v6_6004_0_2, dd_Smed_v6_6004_0_2, [Score=271, Expect=3e-86]} {RNA1509_51791} {RNA1310_26782.1} {RNA815_30571} Mlig455_054626 {REF} {Length: 4315} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=191.9]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=89.5]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=20.7]} {Human: ENSG00000155111, CDK19, cyclin dependent kinase 19, [Score=473, Expect=2e-162]; ENSG00000132964, CDK8, cyclin dependent kinase 8, [Score=470, Expect=7e-162]} {Mouse: ENSMUSG00000029635, Cdk8, cyclin-dependent kinase 8, [Score=471, Expect=2e-162]; ENSMUSG00000038481, Cdk19, cyclin-dependent kinase 19, [Score=471, Expect=4e-162]} {Dmel: FBgn0015618, Cdk8, Cyclin-dependent kinase 8, [Score=462, Expect=4e-159]} {Celegans: WBGene00000409, cdk-8, Cyclin-dependent kinase 8, [Score=417, Expect=9e-140]} {Smed: dd_Smed_v6_6004_0_2, dd_Smed_v6_6004_0_2, [Score=449, Expect=3e-154]} {RNA1509_29840} {RNA1310_20139, RNA1509_29840} {RNA1509_29840, RNA815_12999} |
22. | MligTC455_43345 | 77 | 1.6 | Mlig455_047797 | Neo: - Age: Up-Down-Down Regeneration-upregulated BL: 6.463 Regeneration-enriched BL: 6.463 |
AARS | 0.955 | - | - | - | 0.955 | - | - | Mlig455_047797 {REF} {Length: 2939} {Human: ENSG00000090861, AARS, alanyl-tRNA synthetase, [Score=49.3, Expect=2e-06]} {Mouse: ENSMUSG00000031960, Aars, alanyl-tRNA synthetase, [Score=47.8, Expect=6e-06]} {RNA1509_2824} {RNA1310_45009} {RNA815_1373.1} |
23. | MligTC455_23277 | 53 | 1.09 | Mlig455_019574, Mlig455_059124 | Neo: - Age: - |
CCDC102B | 0.954 | - | - | - | 0.954 | - | - | Mlig455_019574 {REF} {Length: 3576} {TRANSSPLICED} {Human: ENSG00000150636, CCDC102B, coiled-coil domain containing 102B, [Score=97.1, Expect=2e-20]} {Mouse: ENSMUSG00000063605, Ccdc102a, coiled-coil domain containing 102A, [Score=103, Expect=9e-23]} {Dmel: FBgn0051638, CG31638, [RH, Score=120, Expect=7e-28]} {Celegans: WBGene00015646, mlt-10, [Score=145, Expect=6e-36]} {Smed: dd_Smed_v6_13699_0_1, dd_Smed_v6_13699_0_1, [RH, Score=84.0, Expect=3e-17]} {RNA1310_5839.1} {RNA815_37688} Mlig455_059124 {REF} {Length: 1588} {TRANSSPLICED} {Human: ENSG00000150636, CCDC102B, coiled-coil domain containing 102B, [RH, Score=83.2, Expect=6e-17]} {Mouse: ENSMUSG00000063605, Ccdc102a, coiled-coil domain containing 102A, [Score=82.0, Expect=4e-16]} {Dmel: FBgn0051638, CG31638, [Score=100, Expect=6e-22]} {Celegans: WBGene00018763, F53F10.1, [Score=84.7, Expect=2e-18]} {Smed: dd_Smed_v6_13699_0_1, dd_Smed_v6_13699_0_1, [RH, Score=81.3, Expect=1e-16]} {RNA1310_5839.1} {RNA815_37688} |
24. | MligTC455_32507 | 70 | 1.46 | Mlig455_045946, Mlig455_045974 | Neo: - Age: - |
ANKRD28, TANC2 | 0.954 | - | - | - | 0.954 | - | - | Mlig455_045946 {REF} {Length: 5238} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=103.9]; Ankyrin repeats (many copies) [PF13637.8, score=84.5]; Ankyrin repeat [PF13606.8, score=60.9]; Ankyrin repeat [PF00023.32, score=55.3]; Ankyrin repeats (many copies) [PF13857.8, score=50.8]; Mab-21 protein [PF03281.16, score=35.4]} {Human: ENSG00000206560, ANKRD28, ankyrin repeat domain 28, [Score=71.2, Expect=8e-12]; ENSG00000170921, TANC2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=67.8, Expect=1e-10]} {Mouse: ENSMUSG00000053580, Tanc2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=67.8, Expect=9e-11]} {Dmel: FBgn0041096, rols, rolling pebbles, [Score=63.2, Expect=2e-09]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=56.6, Expect=1e-07]} {Smed: dd_Smed_v6_8675_0_1, dd_Smed_v6_8675_0_1, [Score=64.3, Expect=3e-10]} {RNA1509_16149} {RNA1310_1248} {RNA815_6874.1} Mlig455_045974 {REF} {Length: 5344} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=103.7]; Ankyrin repeats (many copies) [PF13637.8, score=84.1]; Ankyrin repeat [PF13606.8, score=60.5]; Ankyrin repeat [PF00023.32, score=55.0]; Ankyrin repeats (many copies) [PF13857.8, score=50.4]; Mab-21 protein [PF03281.16, score=35.3]} {Human: ENSG00000170921, TANC2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=67.8, Expect=1e-10]; ENSG00000039560, RAI14, retinoic acid induced 14, [Score=65.1, Expect=8e-10]} {Mouse: ENSMUSG00000053580, Tanc2, tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2, [Score=67.8, Expect=9e-11]} {Dmel: FBgn0041096, rols, rolling pebbles, [Score=62.8, Expect=2e-09]} {Celegans: WBGene00011240, R11A8.7, Ankyrin repeat and KH domain-containing protein R11A8.7, [Score=56.6, Expect=1e-07]} {Smed: dd_Smed_v6_8675_0_1, dd_Smed_v6_8675_0_1, [Score=64.7, Expect=3e-10]} {RNA1509_16149} {RNA1310_1248} {RNA815_6874.1} |
25. | MligTC455_49675 | 731 | 15.24 | Mlig455_010609 | Neo: - Age: Down-Up-Up |
SHF | 0.954 | - | - | - | 0.954 | - | - | Mlig455_010609 {REF} {Length: 3411} {TRANSSPLICED} {Pfam: SH2 domain [PF00017.26, score=38.9]} {Human: ENSG00000138606, SHF, Src homology 2 domain containing F, [Score=92.0, Expect=7e-21]; ENSG00000105251, SHD, Src homology 2 domain containing transforming protein D, [Score=91.7, Expect=5e-21]} {Mouse: ENSMUSG00000033256, Shf, Src homology 2 domain containing F, [Score=90.9, Expect=4e-21]} {Dmel: FBgn0264542, hwt, heavyweight, [Score=107, Expect=4e-26]} {Smed: dd_Smed_v6_2710_0_1, dd_Smed_v6_2710_0_1, [Score=94.4, Expect=5e-22]} {RNA1509_25407, RNA1509_43439} {RNA1310_33381, RNA1509_25407, RNA1509_43439} {RNA1509_25407, RNA1509_43439, RNA815_11332} |
26. | MligTC455_49829 | 606 | 12.63 | Mlig455_018528 | Neo: - Age: - Region-enriched R8: 5.323/0.00000 |
0.953 | - | - | - | 0.953 | - | - | Mlig455_018528 {REF} {Length: 3314} {Pfam: Plectin repeat [PF00681.22, score=39.5]; SH3 domain [PF17902.3, score=22.5]} {Dmel: FBgn0013733, shot, short stop, [Score=57.0, Expect=9e-08]} {Celegans: WBGene00006952, wrt-6, Warthog protein 6 Warthog protein 6 N-product Warthog protein 6 C-product, [Score=51.2, Expect=3e-06]} {RNA1509_40966} {RNA1310_5072.1} {RNA815_12828} | |
27. | MligTC455_48170 | 120 | 2.49 | Mlig455_006527, Mlig455_070665 | Neo: - Age: - Region-enriched R7: 3.768/0.04650 |
PCDH17 | 0.952 | - | - | - | 0.952 | - | - | Mlig455_006527 {REF} {Length: 3880} {Pfam: Cadherin domain [PF00028.19, score=304.2]; Cadherin-like [PF16184.7, score=28.3]; Cadherin-like [PF08266.14, score=24.0]} {Human: ENSG00000118946, PCDH17, protocadherin 17, [RH, Score=273, Expect=8e-77]} {Mouse: ENSMUSG00000035566, Pcdh17, protocadherin 17, [RH, Score=276, Expect=2e-76]} {Dmel: FBgn0284247, ds, dachsous, [Score=246, Expect=5e-66]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=177, Expect=8e-45]} {Smed: dd_Smed_v6_17019_0_2, dd_Smed_v6_17019_0_2, [RH, Score=345, Expect=1e-101]} {RNA1509_45762} {RNA1310_4962} {RNA815_31557} Mlig455_070665 {REF} {Length: 3977} {Pfam: Cadherin domain [PF00028.19, score=304.6]; Cadherin-like [PF16184.7, score=28.6]; Cadherin-like [PF08266.14, score=24.1]} {Human: ENSG00000118946, PCDH17, protocadherin 17, [RH, Score=273, Expect=5e-77]} {Mouse: ENSMUSG00000035566, Pcdh17, protocadherin 17, [RH, Score=276, Expect=1e-76]} {Dmel: FBgn0284247, ds, dachsous, [Score=246, Expect=5e-66]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=176, Expect=2e-44]} {Smed: dd_Smed_v6_17019_0_2, dd_Smed_v6_17019_0_2, [RH, Score=345, Expect=7e-102]} {RNA1509_45762} {RNA1310_4962, RNA1509_45762} {RNA1509_45762, RNA815_31557} |
28. | MligTC455_15343 | 177 | 3.68 | Mlig455_028996 | Neo: - Age: - Region-enriched R8: 3.572/0.01201 |
PRKG1 | 0.95 | - | - | - | - | 0.950 | - | Mlig455_028996 {REF} {Length: 3220} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=128.3]; Protein kinase domain [PF00069.27, score=57.8]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=32.8]} {Human: ENSG00000185532, PRKG1, protein kinase cGMP-dependent 1, [Score=274, Expect=2e-81]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=273, Expect=3e-81]} {Dmel: FBgn0000721, for, foraging, [Score=286, Expect=7e-86]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=244, Expect=7e-73]} {Smed: dd_Smed_v6_16434_0_1, dd_Smed_v6_16434_0_1, [Score=326, Expect=8e-100]} {RNA1509_32231} {RNA1310_18553.1} {RNA815_13824} |
29. | MligTC455_47769 | 70 | 1.46 | Mlig455_034062 | Neo: - Age: Down-Down-Up |
CHRNA6 | 0.95 | - | - | - | - | 0.950 | - | Mlig455_034062 {REF} {Length: 2693} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=120.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=92.9]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=199, Expect=3e-57]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=195, Expect=8e-56]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=190, Expect=3e-54]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=200, Expect=6e-58]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=198, Expect=3e-57]; ENSMUSG00000066279, Chrna10, cholinergic receptor, nicotinic, alpha polypeptide 10, [Score=193, Expect=1e-55]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=190, Expect=5e-54]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=206, Expect=2e-59]} {Celegans: WBGene00043066, acr-25, AcetylCholine Receptor, [Score=200, Expect=1e-57]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=195, Expect=4e-56]} {RNA1310_10964.1} {RNA815_16260.1} |